{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:54:37Z","timestamp":1787954077798,"version":"build-2784847793"},"reference-count":11,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.jneuroim.2004.09.018","type":"journal-article","created":{"date-parts":[[2004,11,9]],"date-time":"2004-11-09T11:54:11Z","timestamp":1100001251000},"page":"129-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of phospholipids on antiganglioside antibody reactivity in GBS"],"prefix":"10.1016","volume":"159","author":[{"given":"Minako","family":"Hirakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiji","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2004.09.018_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0163-7827(99)00010-7","article-title":"Phospholipids biosynthesis in the yeast Saccharomyces cerevisidae and interrelationship with other metabolic processes","volume":"38","author":"Carman","year":"1999","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jneuroim.2004.09.018_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2004.09.018_bib3","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","article-title":"Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barr\u00e9 syndrome: clinical and immunohistochemical studies","volume":"43","author":"Chiba","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2004.09.018_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(96)01123-7","article-title":"Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome","volume":"745","author":"Chiba","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2004.09.018_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2004.09.018_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-4157(99)00014-3","article-title":"Topology and transport of membrane lipids in bacteria","volume":"1469","author":"Huijbregts","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2004.09.018_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410350510","article-title":"N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barre syndrome","volume":"35","author":"Kusunoki","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2004.09.018_bib8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/mus.10307","article-title":"Binding of immunoglobulin G antibodies in Guillain-Barr\u00e9 syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications","volume":"27","author":"Kusunoki","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2004.09.018_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1084\/jem.179.2.457","article-title":"Anticardiolipin antibodies recognize \u03b22-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface","volume":"179","author":"Matsuura","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2004.09.018_bib10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/brain\/118.4.841","article-title":"Guillain-Barr\u00e9 syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features","volume":"118","author":"Visser","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2004.09.018_bib11","first-page":"235","article-title":"In vivo substrates and the contribution of the common phospholipase D, PLD\u03b1, to wound-induced metabolism of lipids in Arabidopsis","volume":"1530","author":"Zien","year":"2001","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804003595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572804003595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:00:04Z","timestamp":1759046404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572804003595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":11,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0165572804003595"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2004.09.018","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of phospholipids on antiganglioside antibody reactivity in GBS","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2004.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}